
Creative Medical Technology fell 84.7% from $3.05 to $0.47, behind the S&P 500's +10.6%. Its worst day was Jun 26 (−40.0%), and its low came Nov 18 at $0.47.
Nov 18, 2025 – Nov 18, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.80 missed the $-0.37 estimate on $3,000.00 revenue.
+1.1% · S&P 500 +1.1%
EPS of $-0.38 beat the $-0.39 estimate on $0.00 revenue.
Story events cover the past 12 months · Times ET
−5.6% · S&P 500 +0.2%
Creative Medical Technology shares rose 79.0%, while the S&P 500 rose 0.8%.
+79.0%, the year's best day · S&P 500 +0.8%
EPS of $-0.41 missed the $-0.39 estimate on $0.00 revenue.
−15.5% · S&P 500 0.0%
EPS of $-0.40 missed the $-0.24 estimate on $0.00 revenue.
−1.6% · S&P 500 +2.4%
Where it ended: a close of $0.47 on Nov 18, 2026.
Nothing in the past 12 months.
All CELZ analyst actionsNothing in the past 12 months.
All CELZ dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CELZ and SPY from Benzinga historical bars. Not investment advice.